MSB 2.51% 97.0¢ mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-828

  1. 104 Posts.
    lightbulb Created with Sketch. 11
    Fda have been fighting msb all the way but the swamp drainer won't let em win . Big pharma will lose billions and they ain't happy.msb has the answer to a huge range of diseases. I watched a doco on pancreatic cancer last night a mate of mine had this an it killed him quick.in the doco a cytokine storm was said to be a major problem meso blast addresses this problem and many others . President Trump said 6 months ago a new treatment to treat thosands of diseases was on the way and has cut big pharma ability to charge huge prices by up to 80 percent. I for one won't be surprised when msb proves to have the cures the president mentioned
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.